CLU and early-onset autosomal dominant Alzheimer disease: The data presented here lend further support to the contribution of rare coding CLU mutations in the pathogenesis of Alzheimer’s disease, and suggest reduction of secreted CLU as a possible disease mechanism, specifically for a frameshift mutation and two mutations altering the disulfide bridge region of the protein.